YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Avandia
Patients Sue Glaxo Claiming it Suppressed Data on Avandia
Jul 9, 2008 | Parker Waichman Alonso LLP
Two North Carolina patients have sued GlaxoSmithKline claiming its diabetes drug, Avandia, caused their heart attacks. Hundreds more are...
Diabetes Drugs Need Tougher Testing for Heart Risk, FDA Panel Says
Jul 7, 2008 | Parker Waichman Alonso LLP
Last week, a Food & Drug Administration (FDA) advisory panel voted to back tougher testing requirements for diabetes drugs. In a 14-2 vote,...
Avandia Debacle Prompts FDA to Consider New Rules for Approving Diabetes Drugs
Jun 30, 2008 | Parker Waichman Alonso LLP
Federal regulators are mulling over new rules for approving diabetes drugs. The new regulations the Food & Drug Administration (FDA) is...
Ketek, Avandia Among Drugs Doctors Won't Take
Jun 23, 2008 | Parker Waichman Alonso LLP
When doctors were recently asked which commonly prescribed medications they would avoid, they came up with the following eight. Perhaps you...
Outgoing Glaxo Head Says Drugs Should be Tested Sooner, Better
May 20, 2008 | Parker Waichman Alonso LLP
Outgoing head of GlaxoSmithKline (GSK) Jean-Pierre Garnier says the he does not foresee the US Food and Drug Administration (FDA) softening its...
FDA Planning Hiring Blitz
May 1, 2008 | Parker Waichman Alonso LLP
The beleaguered Food & Drug Administration (FDA) is planning on filling over 1,300 positions by the end of September, triple the amount hired by...
Another Study Confirms Avandia, Actos Bone Fracture Risk
Apr 29, 2008 | Parker Waichman Alonso LLP
Avandia, a diabetes drug already mired in controversy, may double the risk of bone fractures, according to a new study. The study, conducted by...
FDA Considering Biomarkers As a Way to Improve Drug Safety
Apr 17, 2008 | Parker Waichman Alonso LLP
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up...
FDA Reprimands Glaxo for Avandia Study
Apr 8, 2008 | Parker Waichman Alonso LLP
The US Food and Drug Administration Federal (FDA) has just issued a warning to the drug maker, GlaxoSmithKline, for not reporting safety results on...
More Heat for Vytorin and Avandia
Mar 5, 2008 | Parker Waichman Alonso LLP
Avandia and Vytorin are the subject of yet another government investigation. The Government Accountability Office (GAO) will look into whether...
Avandia
